Beyond Fractional with Steve Zelenkofske

Steve Zelenkofske has watched emerging biotech companies try to solve the same resourcing problem two ways: hire fractional clinical leadership to save money, or hand execution to an external vendor and accept the distance that comes with it. In his view, both approaches come with limitations that compound over time. In this clip he explains why inSeption’s integrated model is built differently — and why he thinks it’s made for exactly the environment emerging biotech is operating in right now.